Forbes December 5, 2023
Ellen Matloff

Victoria Gray never remembers a moment when she didn’t have sickle cell disease. She was diagnosed with the condition at 3 months of age after she cried so hard during a bath that she was taken to the emergency room. For Gray, who has no close relatives with the disorder, that was the beginning of unrelenting pain, ER visits, hospitalizations and treatments that robbed her of much of her childhood and adult life.

Gray became unable to take care of herself and her family. In hopes that she could improve her life by even 50%, Gray bravely chose to be the first patient to enter a clinical trial using a CRISPR editing drug to treat sickle cell disease. Four and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma / Biotech
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article